Reaction: Latanoprost to 1 product

Reaction
Latanoprost
DB00654
Latanoprost acid
DBMET02771
Reaction type
esterase hydrolysis
Direction
Major circulating metabolite?
No
Spontaneous?
No
Activity
unknown
References
  1. Patel SS, Spencer CM: Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging. 1996 Nov;9(5):363-78. doi: 10.2165/00002512-199609050-00007. [Article]
  2. Alm A: Latanoprost in the treatment of glaucoma. Clin Ophthalmol. 2014 Sep 26;8:1967-85. doi: 10.2147/OPTH.S59162. eCollection 2014. [Article]
  3. FDA Approved Drug Products: Xalatan (latanoprost) Ophthalmic Solution [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Corneal esterasesNot AvailableNot Availableconfirmed